Patent · US Expired

Use of stilbene compounds in the manufacture of medicament for the prevention and treatment of diabetes or retrovirus-associated diseases

US7384920B2 · kind B2 · utility

6Cited by

4References

1Claims

0Family size

Assignees

Institute of radiation medicine, academy of military medical sciences, PLA. · CN
Beijing Luyin Lihua Pharmaceutical Science and Technology Development Company Ltd · CN

Inventors

Junlin Li · Atlanta, US
Zuze Wu · Beijing, CN
Lizhen Yuan · Beijing, CN
Qiang Li · Beijing, CN
Zhongxiong Tang · Beijing, CN

Key dates

Filing date	Jul 26, 2001
Grant date	Jun 10, 2008
Priority date	—
Expiry date	Mar 2, 2022

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P31/18
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to a new use of stilbene derivatives or pharmaceutically acceptable salts thereof, especially in the manufacture of medicament for the prevention and treatment of diabetes or retrovirus associated diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.